Drug ads misleading – even in medical journals
Drug advertising directly to consumers
has been shown to be filled with inaccuracies, overstated benefits, and
glaring omissions of information. Shockingly, a new research study shows
that drug ads in medical journals – directly to medical doctors – also
provide inaccurate information!
Researchers from Spain, published in the
British medical journal The Lancet, reviewed all advertisements for
antihypertensive and lipid-lowering drugs published in six Spanish medical
journals in 1997 that had at least one bibliographical reference. Two pairs
of investigators independently analyzed the advertisements to see whether
the studies quoted in the ad as endorsing the advertising message actually
supported the corresponding claims.
Drug companies often include such
references in hopes of convincing medical doctors that their products have
been “proven” effective by medical research. “We aimed to assess whether the
references about efficacy, safety, convenience, or cost of antihypertensive
and lipid-lowering drugs included in advertisements supported the
promotional claims,” the researchers explained.
The researchers identified 264 different
advertisements for antihypertensive drugs, and 23 different advertisements
for lipid-lowering drugs in the medical journals they studied. A total of
125 promotional claims were “backed up” by references to research studies.
Yet, the researchers found that 45 of these promotional statements were
NOT supported by the reference, most frequently because the slogan
recommended the drug in a patient group other than that assessed in the
study (for instance, a drug company might advertise a drug for women, yet
the study they reference in the ad involved only men).
Nearly one-fifth of all the references,
(18%) were from monographic works and non-published data which that the
researchers couldn’t retrieve.
“Doctors should be cautious in
assessment of advertisements that claim a drug has greater efficacy, safety,
or convenience, even though these claims are accompanied by bibliographical
references to randomised clinical trials published in reputable medical
journals and seem to be evidence-based,” the researchers warned.
The report also noted that some drug ads
actually use images of various high-profile medical journals as a means of
increasing the credibility of their claims.
SOURCE:
“Accuracy of pharmaceutical advertisements in medical journals,” The
Lancet, Volume 361, Number 9351, Jan. 4, 2003.